NCT03519412 2026-03-03
ARETHUSA
IFOM ETS - The AIRC Institute of Molecular Oncology
Phase 2 Completed
Clinical Trials
21 trialsNCT06659705 2025-12-18
INDIGO-FAPI
Institut Curie
Phase 2 Recruiting
NCT07091032 2025-11-18
Building Connections
Massachusetts General Hospital
Phase NA Recruiting
NCT06180460 2025-10-08
CALM: Managing Distress in Malignant Brain Cancer
Virginia Commonwealth University
Phase NA Completed
NCT00819208 2025-09-16
CHALLENGE
Canadian Cancer Trials Group
Phase NA Active not recruiting
NCT03742596 2023-03-15
Effect of Probiotics Supplementation on the Side Effects of Radiation Therapy Among Colorectal Cancer Patients
King Hussein Cancer Center
Phase 2/3 Withdrawn
NCT05617430 2022-11-15
Combination Therapy of HAIC, Sintilimab and Bevacizumab for Advanced Hepatocellular Carcinoma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase 2 Unknown
NCT02798224 2022-10-25
A Patient Portal Tool, E-assist, for Supporting CRC Screening
UNC Lineberger Comprehensive Cancer Center
Phase NA Completed
NCT05231382 2022-05-24
Hepatic Arterial Infusion of Raltetrexed With Oxaliplatin(SALOX) Versus FOLFOX in Advanced Hepatocellular Carcinoma
Sun Yat-sen University
Phase 3 Unknown
NCT04298398 2020-10-22
MindGAP-P
Instituto Portugues de Oncologia, Francisco Gentil, Porto
Phase NA Unknown
NCT01534637 2018-08-15
Aprepitant in Preventing Nausea and Vomiting in Patients Undergoing Chemotherapy and Radiation Therapy for Pancreatic Cancer
Wake Forest University Health Sciences
Phase 2 Completed
NCT00316862 2018-05-08
Cisplatin, Irinotecan, and Radiation Therapy in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By Surgery
Alliance for Clinical Trials in Oncology
Phase 2 Completed
NCT00114231 2018-03-29
Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage I Rectal Cancer
Alliance for Clinical Trials in Oncology
Phase 2 Completed
NCT02840331 2017-10-27
Hypericin-PDT
University Hospital Tuebingen
Phase 3 Unknown
NCT00769106 2016-04-14
HCC-CIK
Sun Yat-sen University
Phase 3 Completed
NCT02148406 2015-06-23
Pro-You
Vanderbilt-Ingram Cancer Center
Phase NA Completed
NCT00827177 2014-01-24
Dose Escalation Study of ARQ 197 in Combination With Sorafenib in Adult Patients With Advanced Solid Tumors
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)
Phase 1 Completed
NCT01456923 2011-10-21
Chemotherapy With DNA Damaging Agents In Colorectal Cancer
Centro Hospitalar Nordeste
Phase 1 Completed
NCT00335491 2011-09-30
Exercise in Improving Mobility and Reducing Fatigue and/or Weakness in Older Cancer Survivors
University of Utah
Phase NA Completed
NCT00900835 2011-03-07
Pain and Fatigue Management in Patients With Breast Cancer, Prostate Cancer, Colon Cancer, or Lung Cancer
City of Hope Medical Center
Phase NA Completed
NCT00902733 2010-10-01
Nurse-Provided Care or Standard Care in Treating Patients With Pancreatic Cancer
City of Hope Medical Center
Phase NA Completed